‘Need to develop capability to enhance cross border pharma e-com trade’

I believe 70-75 % of generic drugs today are exported to Europe and USA from India. Our pharma industry is doing a fantastic job and getting regular FDA nods from the US Drug administrators, affirms Tushar Jani, Group Chairman, CSC. Go to any pharmacy abroad, you will find Indian generic drugs. The important factor is this development enables us to build cross border pharma e-commerce capabilities out of India, says Tushar Jani, Group Chairman, CSC. He adds, “If we develop the capability of providing pharma e-commerce services, the world will recognize us, and that is what is needed. Domestic pharma industry would benefit greatly from this vision. We must develop our skills for product delivery to Europe and the USA in a controlled manner.”